Quoin Pharmaceuticals (QNRX) EPS (Basic) (2021 - 2023)
Quoin Pharmaceuticals (QNRX) posted EPS (Basic) of -$45.51 for Q4 2023, down 16.59% sequentially from -$39.03 in Q3 2023, and up 99.93% YoY from -$22.76 in Q4 2022.
Quoin Pharmaceuticals (QNRX) EPS (Basic) (2021 - 2023) Analysis & Trends
Quoin Pharmaceuticals has reported EPS (Basic) for 3 years, with the latest figure at -$45.51 in Q4 2023.
- Quarterly EPS (Basic) rose 99.93% year-over-year to -$45.51 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$8.12 (up 89.8% YoY) and the FY2023 annual result came in at -$192.84, up 99.94% from the prior year.
- EPS (Basic) retreated to -$45.51 in Q4 2023 per QNRX's latest filing, from -$39.03 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$39.03 in Q3 2023 and troughed at -$468045.3 in Q3 2021.
- A 3-year average of -$103710.6 and a median of -$38381.4 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) slumped 788.68% in 2022, then soared 99.95% in 2023.
- Over 3 years, EPS (Basic) stood at -$7764.2 in 2021, then plunged by 788.68% to -$68998.6 in 2022, then surged by 99.93% to -$45.51 in 2023.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$45.51, -$39.03, and -$68998.6 for Q4 2023, Q3 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 0.18 |
| 10 | Quoin Pharmaceuticals | 519,367.75 | 519,367.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -45.51 |
| Sep 30, 2023 | -39.03 |
| Dec 31, 2022 | -68,998.62 |
| Sep 30, 2022 | -77,370.83 |
| Dec 31, 2021 | -7,764.15 |
| Sep 30, 2021 | -468,045.33 |